The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis
Abstract Background Retinopathy of prematurity (ROP) is typically treated with laser photocoagulation and/or intravitreal anti-vascular endothelial growth factor (anti-VEGF). To the best of our knowledge, most systematic reviews have focused on comparing anti-VEGF against laser treatment while compa...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2023-10-01
|
| Schriftenreihe: | Italian Journal of Pediatrics |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s13052-023-01543-3 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|